ARTICLE27
What an FDA Warning Letter Tells Us About AI, Human Oversight, and Getting Validation Right
DEV.to AIΒ·May 14, 2026
An FDA warning letter to Purolea Cosmetics Lab revealed quality process breakdowns due to a lack of qualified human oversight. The article uses this as a lesson for AI validation in life sciences, stressing that human expertise is crucial for directing and reviewing AI outputs, rather than just AI's capabilities.
Read original β